Pharma

Alembic Pharmaceuticals recieves USFDA approval for Opthalmic Solution.

Alembic Pharmaceuticals recieves USFDA approval for Opthalmic Solution.

Drug firm Alembic Pharmaceuticals on Wednesday said it has received approval from the US health regulator for Dorzolamide Hydrochloride and Timolol Maleate Ophthalmic Solution, used to treat certain types of glaucoma and other causes of high pressure inside the eye. The approved product is therapeutically equivalent to the reference listed drug product (RLD) Cosopt Ophthalmic Solution, 2 per cent and 0.5 per cent, of Akorn Operating Company LLC. The company has received approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug application…
Read More
Alembic Pharmaceuticals Net Revenue increases 17% to Rs 5393 crores

Alembic Pharmaceuticals Net Revenue increases 17% to Rs 5393 crores

Net Profit up 42% to Rs 1178 crores for the yearAlembic Pharmaceuticals Limited reported its consolidated financial results for the period ending 31st March 2021. Financial Highlights for the QuarterNet Sales for the quarter up 6% to Rs 1280 crores.Net Profit for the quarter up 12% to Rs 251 crores from Rs 225 crores. Financial Highlights for the YearNet sales for FY21 up 17% to Rs 5393 crores against Rs 4606 crores.Net profit for FY21 up 42% to Rs 1178 crores from Rs 829 crores. Mr. Pranav…
Read More
Prices of Ramdesivir slashed on orders of National Pharma authorities.

Prices of Ramdesivir slashed on orders of National Pharma authorities.

The National Pharmaceutical Pricing Authority under the Department of Pharmaceuticals declared change in prices for seven brands of Remdesivir injections of potency 100mg per vial Pharmaceutical companies manufacturing the anti-COVID medicine Remdesivir in India have voluntarily slashed prices following government intervention, National Pharmaceutical Pricing Authority under the Department of Pharmaceuticals announced on Saturday. The authority declared change in prices for seven brands of Remdesivir injections of potency 100mg per vial. After the price cuts, ranging from Rs 1,000 to Rs 2,700, Cadila Healthcare's Remdac continues to be…
Read More
Profit before Tax up 36% to Rs 406 crores for the quarter

Profit before Tax up 36% to Rs 406 crores for the quarter

Net Profit up 35% to Rs 333 crores Vadodara, October 22nd, 2020 Alembic Pharmaceuticals Limited reported its consolidated financial results for the quarter ending 30th September 2020. Financial Highlights Net Sales for the quarter up 17% to Rs 1457 crores from Rs. 1241 crores.Net Profit for the quarter up 35% to Rs 333 crores from Rs 246 crores.Net sales for H-1 FY21 up 28% to Rs 2798 crores against Rs 2190 crores.Net profit for H-1 FY21 up 72% to Rs 635 crores from Rs 370 crores. Mr.…
Read More
No widgets found. Go to Widget page and add the widget in Offcanvas Sidebar Widget Area.